Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new revision tag Revision: v3.5.4 is displayed, replacing Revision: v3.5.3, indicating a platform release update. This change does not modify the study data or how users access the page.
    Difference
    0.1%
    Check dated 2026-05-15T15:15:47.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s interface/version footer was updated from Revision v3.5.2 to v3.5.3, reflecting a software release rather than any change to the clinical study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:08.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:00.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added site revision note: v3.5.0; removed revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:09:13.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:20:26.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the previous funding-status notice (lapse in government funding) and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:01.000Z thumbnail image

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.